Past studies evaluating the connection between GLP-1 treatment and Alzheimers risk or development have mostly drawn from data on the injectables, raising questions on whether changing how people take the drug or the dosage could elicit a different outcome, Drucker says, though he adds that giving higher doses to some older adults may also come with additional risks
This gift card subscription comes with a2 orders minimum commitment
Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study
Probiotic properties of exopolysaccharide producing lactic acid bacteria isolated from vegetables and traditional Indian fermented foods
Presented for research literature review only Agarwal R (2025)